Chrysemys picta bellii isolate RCT428 chromosome 13, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002665.2.\nOn Aug 10, 2021 this sequence version replaced NC_024228.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 14A16-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins
uncharacterized LOC101953150, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC101953150, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC101953150, transcript variant X11
uncharacterized LOC101953150, transcript variant X14
uncharacterized LOC101953150, transcript variant X8
uncharacterized LOC101953150, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC101953150, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC101953150, transcript variant X13
uncharacterized LOC101953150, transcript variant X7
uncharacterized LOC101953150, transcript variant X16
uncharacterized LOC101953150, transcript variant X6
uncharacterized LOC101953150, transcript variant X9
uncharacterized LOC101953150, transcript variant X3
uncharacterized LOC101953150, transcript variant X1
uncharacterized LOC101953150, transcript variant X12
uncharacterized LOC101953150, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC101953150, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC101952244, transcript variant X2
uncharacterized LOC101952244, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC101951893, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC101951893, transcript variant X5
uncharacterized LOC101951893, transcript variant X4
uncharacterized LOC101951893, transcript variant X2
uncharacterized LOC101951893, transcript variant X1
zinc finger protein 34-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X5
zinc finger protein 34-like, transcript variant X8
zinc finger protein 34-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X6
phospholipid transfer protein C2CD2L isoform X3
phospholipid transfer protein C2CD2L isoform X1
phospholipid transfer protein C2CD2L isoform X5
phospholipid transfer protein C2CD2L isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
phospholipid transfer protein C2CD2L isoform X4
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
porphobilinogen deaminase, transcript variant X1
porphobilinogen deaminase, transcript variant X2
porphobilinogen deaminase, transcript variant X3
vacuolar protein sorting-associated protein 11 homolog isoform X1
vacuolar protein sorting-associated protein 11 homolog isoform X2
VPS11 core subunit of CORVET and HOPS complexes, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
VPS11 core subunit of CORVET and HOPS complexes, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
vacuolar protein sorting-associated protein 11 homolog
hypoxia up-regulated 1, transcript variant X3
hypoxia up-regulated protein 1 isoform X3
hypoxia up-regulated 1, transcript variant X1
hypoxia up-regulated 1, transcript variant X2
hypoxia up-regulated protein 1 isoform X1
hypoxia up-regulated protein 1 isoform X2
hypoxia up-regulated 1, transcript variant X4
hypoxia up-regulated 1, transcript variant X5
hypoxia up-regulated protein 1 isoform X4
uncharacterized LOC122173867, transcript variant X1
uncharacterized LOC122173867, transcript variant X2
solute carrier family 37 member 4, transcript variant X1
solute carrier family 37 member 4, transcript variant X4
solute carrier family 37 member 4, transcript variant X5
solute carrier family 37 member 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 37 member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 37 member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 37 member 4, transcript variant X2
solute carrier family 37 member 4, transcript variant X3
glucose-6-phosphate exchanger SLC37A4 isoform X1
glucose-6-phosphate exchanger SLC37A4 isoform X2
glucose-6-phosphate exchanger SLC37A4 isoform X3
trafficking protein particle complex subunit 4
ribosomal protein S25, transcript variant X1
ribosomal protein S25, transcript variant X2
centrosomal AT-AC splicing factor, transcript variant X3
centrosomal AT-AC splicing factor, transcript variant X1
centrosomal AT-AC splicing factor, transcript variant X2
centrosomal AT-AC splicing factor isoform X1
centrosomal AT-AC splicing factor isoform X2
centrosomal AT-AC splicing factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
centrosomal AT-AC splicing factor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: B-cell CLL/lymphoma 9-like protein
C-X-C motif chemokine receptor 5, transcript variant X1
C-X-C motif chemokine receptor 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
C-X-C motif chemokine receptor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
DEAD-box helicase 6, transcript variant X2
DEAD-box helicase 6, transcript variant X1
probable ATP-dependent RNA helicase DDX6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X5
pleckstrin homology like domain family B member 1, transcript variant X3
pleckstrin homology like domain family B member 1, transcript variant X4
pleckstrin homology like domain family B member 1, transcript variant X1
pleckstrin homology like domain family B member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X14
pleckstrin homology like domain family B member 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X2
pleckstrin homology like domain family B member 1, transcript variant X24
pleckstrin homology like domain family B member 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X20
pleckstrin homology like domain family B member 1, transcript variant X25
pleckstrin homology like domain family B member 1, transcript variant X26
pleckstrin homology like domain family B member 1, transcript variant X28
pleckstrin homology like domain family B member 1, transcript variant X29
pleckstrin homology like domain family B member 1, transcript variant X33
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X35
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X36
pleckstrin homology like domain family B member 1, transcript variant X37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X34
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X40
pleckstrin homology like domain family B member 1, transcript variant X38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X41
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X21
pleckstrin homology like domain family B member 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X10
pleckstrin homology like domain family B member 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X23
pleckstrin homology like domain family B member 1, transcript variant X27
pleckstrin homology like domain family B member 1, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
pleckstrin homology like domain family B member 1, transcript variant X32
pleckstrin homology-like domain family B member 1 isoform X36
pleckstrin homology-like domain family B member 1 isoform X35
pleckstrin homology-like domain family B member 1 isoform X33
pleckstrin homology-like domain family B member 1 isoform X31
pleckstrin homology-like domain family B member 1 isoform X30
pleckstrin homology-like domain family B member 1 isoform X32
pleckstrin homology-like domain family B member 1 isoform X29
pleckstrin homology-like domain family B member 1 isoform X26
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X18
pleckstrin homology-like domain family B member 1 isoform X34
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X11
pleckstrin homology-like domain family B member 1 isoform X28
pleckstrin homology-like domain family B member 1 isoform X24
pleckstrin homology-like domain family B member 1 isoform X20
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology-like domain family B member 1 isoform X25
pleckstrin homology-like domain family B member 1 isoform X21
pleckstrin homology-like domain family B member 1 isoform X12
pleckstrin homology-like domain family B member 1 isoform X22
pleckstrin homology-like domain family B member 1 isoform X15
pleckstrin homology-like domain family B member 1 isoform X13
pleckstrin homology-like domain family B member 1 isoform X8
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X14
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology-like domain family B member 1 isoform X19
pleckstrin homology-like domain family B member 1 isoform X23
pleckstrin homology-like domain family B member 1 isoform X27
pleckstrin homology-like domain family B member 1 isoform X17
pleckstrin homology-like domain family B member 1 isoform X16
intraflagellar transport 46, transcript variant X1
intraflagellar transport 46, transcript variant X2
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X2
transmembrane protein 25, transcript variant X2
transmembrane protein 25, transcript variant X1
lysine methyltransferase 2A, transcript variant X4
lysine methyltransferase 2A, transcript variant X3
lysine methyltransferase 2A, transcript variant X5
lysine methyltransferase 2A, transcript variant X1
lysine methyltransferase 2A, transcript variant X2
histone-lysine N-methyltransferase 2A isoform X3
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X4
histone-lysine N-methyltransferase 2A isoform X1
lysine methyltransferase 2A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lysine methyltransferase 2A, transcript variant X6
histone-lysine N-methyltransferase 2A isoform X6
histone-lysine N-methyltransferase 2A isoform X5
ubiquitination factor E4A, transcript variant X3
ubiquitination factor E4A, transcript variant X4
ubiquitination factor E4A, transcript variant X1
ubiquitination factor E4A, transcript variant X2
ubiquitin conjugation factor E4 A isoform X2
ubiquitin conjugation factor E4 A isoform X3
ubiquitin conjugation factor E4 A isoform X1
T-cell surface glycoprotein CD3 gamma chain-like
T-cell surface glycoprotein CD3 epsilon chain
myelin protein zero like 3, transcript variant X2
myelin protein zero like 3, transcript variant X1
myelin protein zero-like protein 3 isoform X2
myelin protein zero-like protein 3 isoform X1
junction adhesion molecule like, transcript variant X1
junction adhesion molecule like, transcript variant X2
junctional adhesion molecule-like isoform X1
junctional adhesion molecule-like isoform X2
sodium voltage-gated channel beta subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
sodium voltage-gated channel beta subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
FXYD domain-containing ion transport regulator 6
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: FXYD domain-containing ion transport regulator 6
DS cell adhesion molecule like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DS cell adhesion molecule like 1, transcript variant X1
Down syndrome cell adhesion molecule-like protein 1 isoform X1
Down syndrome cell adhesion molecule-like protein 1 isoform X2
uncharacterized LOC122173870, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122173870, transcript variant X1
centrosomal protein 164, transcript variant X4
centrosomal protein 164, transcript variant X3
centrosomal protein 164, transcript variant X2
centrosomal protein 164, transcript variant X1
centrosomal protein of 164 kDa isoform X4
centrosomal protein of 164 kDa isoform X3
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X1
proprotein convertase subtilisin/kexin type 7
SID1 transmembrane family member 2, transcript variant X8
SID1 transmembrane family member 2, transcript variant X6
SID1 transmembrane family member 2, transcript variant X5
SID1 transmembrane family member 2, transcript variant X2
SID1 transmembrane family member 2, transcript variant X7
SID1 transmembrane family member 2, transcript variant X4
SID1 transmembrane family member 2, transcript variant X3
SID1 transmembrane family member 2, transcript variant X1
SID1 transmembrane family member 2 isoform X8
SID1 transmembrane family member 2 isoform X6
SID1 transmembrane family member 2 isoform X5
SID1 transmembrane family member 2 isoform X2
SID1 transmembrane family member 2 isoform X7
SID1 transmembrane family member 2 isoform X4
SID1 transmembrane family member 2 isoform X3
SID1 transmembrane family member 2 isoform X1
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X3
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X2
platelet activating factor acetylhydrolase 1b catalytic subunit 2, transcript variant X1
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X2
platelet-activating factor acetylhydrolase IB subunit alpha2 isoform X1
SIK family kinase 3, transcript variant X1
SIK family kinase 3, transcript variant X2
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X5
SIK family kinase 3, transcript variant X6
SIK family kinase 3, transcript variant X7
SIK family kinase 3, transcript variant X4
SIK family kinase 3, transcript variant X8
SIK family kinase 3, transcript variant X9
SIK family kinase 3, transcript variant X10
SIK family kinase 3, transcript variant X11
SIK family kinase 3, transcript variant X12
SIK family kinase 3, transcript variant X13
SIK family kinase 3, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
serine/threonine-protein kinase SIK3 isoform X1
serine/threonine-protein kinase SIK3 isoform X3
serine/threonine-protein kinase SIK3 isoform X2
serine/threonine-protein kinase SIK3 isoform X4
serine/threonine-protein kinase SIK3 isoform X5
serine/threonine-protein kinase SIK3 isoform X6
serine/threonine-protein kinase SIK3 isoform X7
serine/threonine-protein kinase SIK3 isoform X11
SIK family kinase 3, transcript variant X14
serine/threonine-protein kinase SIK3 isoform X8
SIK family kinase 3, transcript variant X15
serine/threonine-protein kinase SIK3 isoform X9
SIK family kinase 3, transcript variant X16
serine/threonine-protein kinase SIK3 isoform X10
apolipoprotein A5, transcript variant X2
apolipoprotein A5, transcript variant X1
stabilizer of axonemal microtubules 2-like, transcript variant X3
stabilizer of axonemal microtubules 2-like, transcript variant X4
stabilizer of axonemal microtubules 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
stabilizer of axonemal microtubules 2-like, transcript variant X2
stabilizer of axonemal microtubules 2-like isoform X2
uncharacterized protein LOC101932618 isoform X4
stabilizer of axonemal microtubules 2-like isoform X1
uncharacterized protein LOC101932618 isoform X3
uncharacterized LOC101932444, transcript variant X1
uncharacterized LOC101932444, transcript variant X2
cell adhesion molecule 1, transcript variant X1
cell adhesion molecule 1, transcript variant X3
cell adhesion molecule 1, transcript variant X4
cell adhesion molecule 1, transcript variant X5
cell adhesion molecule 1, transcript variant X6
cell adhesion molecule 1, transcript variant X2
neurexophilin and PC-esterase domain family member 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NXPE family member 4
RNA binding motif protein 7, transcript variant X2
RNA binding motif protein 7, transcript variant X1
uncharacterized LOC112060154, transcript variant X2
uncharacterized LOC112060154, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nicotinamide N-methyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
nicotinamide N-methyltransferase-like isoform X1
nicotinamide N-methyltransferase-like, transcript variant X2
indolethylamine N-methyltransferase-like isoform X2
zinc finger and BTB domain containing 16
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 28, transcript variant X1
ubiquitin specific peptidase 28, transcript variant X4
ubiquitin specific peptidase 28, transcript variant X7
ubiquitin specific peptidase 28, transcript variant X8
ubiquitin specific peptidase 28, transcript variant X6
ubiquitin specific peptidase 28, transcript variant X5
ubiquitin specific peptidase 28, transcript variant X3
ubiquitin specific peptidase 28, transcript variant X11
ubiquitin carboxyl-terminal hydrolase 28 isoform X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X4
ubiquitin carboxyl-terminal hydrolase 28 isoform X7
ubiquitin carboxyl-terminal hydrolase 28 isoform X8
ubiquitin carboxyl-terminal hydrolase 28 isoform X6
ubiquitin carboxyl-terminal hydrolase 28 isoform X5
ubiquitin carboxyl-terminal hydrolase 28 isoform X3
ubiquitin specific peptidase 28, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 28 isoform X2
ubiquitin specific peptidase 28, transcript variant X9
ubiquitin carboxyl-terminal hydrolase 28 isoform X9
ubiquitin specific peptidase 28, transcript variant X10
ubiquitin carboxyl-terminal hydrolase 28 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
G protein-activated inward rectifier potassium channel 4-like, transcript variant X4
G protein-activated inward rectifier potassium channel 4-like, transcript variant X3
G protein-activated inward rectifier potassium channel 4-like, transcript variant X2
G protein-activated inward rectifier potassium channel 4-like, transcript variant X1
G protein-activated inward rectifier potassium channel 4-like
zw10 kinetochore protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zw10 kinetochore protein, transcript variant X4
zw10 kinetochore protein, transcript variant X1
zw10 kinetochore protein, transcript variant X5
zw10 kinetochore protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
centromere/kinetochore protein zw10 homolog
transmembrane serine protease 5, transcript variant X2
transmembrane serine protease 5, transcript variant X1
transmembrane protease serine 5 isoform X1
transmembrane protease serine 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ankyrin repeat and kinase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and protein kinase domain-containing protein 1
tetratricopeptide repeat domain 12, transcript variant X3
tetratricopeptide repeat domain 12, transcript variant X1
tetratricopeptide repeat domain 12, transcript variant X2
tetratricopeptide repeat domain 12, transcript variant X4
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat protein 12 isoform X1
tetratricopeptide repeat protein 12 isoform X3
tetratricopeptide repeat domain 12, transcript variant X5
tetratricopeptide repeat protein 12 isoform X4
neural cell adhesion molecule 1, transcript variant X2
neural cell adhesion molecule 1, transcript variant X1
neural cell adhesion molecule 1, transcript variant X5
neural cell adhesion molecule 1, transcript variant X3
neural cell adhesion molecule 1, transcript variant X4
neural cell adhesion molecule 1, transcript variant X7
neural cell adhesion molecule 1, transcript variant X10
neural cell adhesion molecule 1, transcript variant X9
neural cell adhesion molecule 1, transcript variant X6
neural cell adhesion molecule 1, transcript variant X13
neural cell adhesion molecule 1, transcript variant X8
neural cell adhesion molecule 1, transcript variant X12
neural cell adhesion molecule 1, transcript variant X11
neural cell adhesion molecule 1 isoform X13
neural cell adhesion molecule 1 isoform X5
neural cell adhesion molecule 1 isoform X11
neural cell adhesion molecule 1 isoform X4
neural cell adhesion molecule 1 isoform X12
neural cell adhesion molecule 1 isoform X10
neural cell adhesion molecule 1 isoform X3
neural cell adhesion molecule 1 isoform X9
neural cell adhesion molecule 1 isoform X8
neural cell adhesion molecule 1 isoform X2
neural cell adhesion molecule 1 isoform X7
neural cell adhesion molecule 1 isoform X6
neural cell adhesion molecule 1 isoform X1
neural cell adhesion molecule 1, transcript variant X15
neural cell adhesion molecule 1, transcript variant X16
neural cell adhesion molecule 1, transcript variant X14
neural cell adhesion molecule 1, transcript variant X19
neural cell adhesion molecule 1, transcript variant X18
neural cell adhesion molecule 1, transcript variant X17
neural cell adhesion molecule 1 isoform X19
neural cell adhesion molecule 1 isoform X17
neural cell adhesion molecule 1 isoform X18
neural cell adhesion molecule 1 isoform X16
neural cell adhesion molecule 1 isoform X15
neural cell adhesion molecule 1 isoform X14
placenta-expressed transcript 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
beta-carotene oxygenase 2, transcript variant X1
beta-carotene oxygenase 2, transcript variant X2
beta,beta-carotene 9',10'-oxygenase isoform X1
beta,beta-carotene 9',10'-oxygenase isoform X2
translocase of inner mitochondrial membrane 8 homolog B
mitochondrial import inner membrane translocase subunit Tim8 B
NKAP domain containing 1, transcript variant X2
NKAP domain containing 1, transcript variant X1
NKAP domain containing 1, transcript variant X3
PIH1 domain containing 2, transcript variant X1
PIH1 domain-containing protein 2 isoform X1
PIH1 domain containing 2, transcript variant X2
PIH1 domain-containing protein 2 isoform X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
DIX domain containing 1, transcript variant X2
DIX domain containing 1, transcript variant X4
DIX domain containing 1, transcript variant X3
DIX domain containing 1, transcript variant X1
DIX domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 114 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C11orf52 homolog
heat shock protein family B (small) member 2
crystallin alpha B, transcript variant X1
crystallin alpha B, transcript variant X2
chromosome 13 C11orf1 homolog, transcript variant X1
chromosome 13 C11orf1 homolog, transcript variant X2
chromosome 13 C11orf1 homolog, transcript variant X3
UPF0686 protein C11orf1 homolog isoform X2
UPF0686 protein C11orf1 homolog isoform X1
ferredoxin-fold anticodon binding domain containing 1, transcript variant X1
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X1
ferredoxin-fold anticodon binding domain containing 1, transcript variant X2
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X2
ALG9 alpha-1,2-mannosyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ALG9 alpha-1,2-mannosyltransferase, transcript variant X1
ALG9 alpha-1,2-mannosyltransferase, transcript variant X3
alpha-1,2-mannosyltransferase ALG9 isoform X1
alpha-1,2-mannosyltransferase ALG9 isoform X2
salt inducible kinase 2, transcript variant X3
salt inducible kinase 2, transcript variant X1
salt inducible kinase 2, transcript variant X2
serine/threonine-protein kinase SIK2 isoform X1
serine/threonine-protein kinase SIK2 isoform X2
HOATZ cilia and flagella associated protein, transcript variant X2
HOATZ cilia and flagella associated protein, transcript variant X1
HOATZ cilia and flagella associated protein, transcript variant X4
cilia- and flagella-associated protein HOATZ isoform X2
cilia- and flagella-associated protein HOATZ isoform X1
cilia- and flagella-associated protein HOATZ isoform X3
HOATZ cilia and flagella associated protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
POU class 2 homeobox associating factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C11orf53 homolog
CUB and sushi domain-containing protein 3-like
ATP binding cassette subfamily G member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATP-binding cassette sub-family G member 4 isoform X1
ATP binding cassette subfamily G member 4, transcript variant X2
ATP-binding cassette sub-family G member 4 isoform X2
NLR family member X1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
NLR family member X1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
PDZ domain containing 3, transcript variant X2
PDZ domain containing 3, transcript variant X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 isoform X1
coiled-coil domain containing 153, transcript variant X2
coiled-coil domain containing 153, transcript variant X1
coiled-coil domain-containing protein 153 isoform X2
coiled-coil domain-containing protein 153 isoform X1
Cbl proto-oncogene, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Cbl proto-oncogene, transcript variant X1
E3 ubiquitin-protein ligase CBL isoform X1
E3 ubiquitin-protein ligase CBL isoform X2
melanoma cell adhesion molecule, transcript variant X2
melanoma cell adhesion molecule, transcript variant X3
melanoma cell adhesion molecule, transcript variant X1
cell surface glycoprotein MUC18 isoform X2
cell surface glycoprotein MUC18 isoform X1
cell surface glycoprotein MUC18 isoform X3
uncharacterized LOC112059044, transcript variant X4
uncharacterized LOC112059044, transcript variant X3
uncharacterized LOC112059044, transcript variant X5
uncharacterized LOC112059044, transcript variant X2
uncharacterized LOC112059044, transcript variant X1
complement C1q tumor necrosis factor-related protein 5
ubiquitin specific peptidase 2, transcript variant X4
ubiquitin specific peptidase 2, transcript variant X2
ubiquitin specific peptidase 2, transcript variant X3
ubiquitin specific peptidase 2, transcript variant X7
ubiquitin specific peptidase 2, transcript variant X1
ubiquitin specific peptidase 2, transcript variant X5
ubiquitin specific peptidase 2, transcript variant X6
ubiquitin specific peptidase 2, transcript variant X10
ubiquitin specific peptidase 2, transcript variant X9
ubiquitin carboxyl-terminal hydrolase 2 isoform X2
ubiquitin carboxyl-terminal hydrolase 2 isoform X1
ubiquitin carboxyl-terminal hydrolase 2 isoform X4
ubiquitin carboxyl-terminal hydrolase 2 isoform X3
ubiquitin specific peptidase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X1
nectin cell adhesion molecule 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nectin cell adhesion molecule 1, transcript variant X2
tripartite motif containing 29, transcript variant X2
tripartite motif containing 29, transcript variant X1
tripartite motif-containing protein 29 isoform X2
tripartite motif-containing protein 29 isoform X1
POU domain, class 2, transcription factor 3
TLC domain-containing protein 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TLC domain-containing protein 5-like, transcript variant X2
TLC domain-containing protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 12, transcript variant X1
Rho guanine nucleotide exchange factor 12, transcript variant X2
Rho guanine nucleotide exchange factor 12, transcript variant X4
Rho guanine nucleotide exchange factor 12, transcript variant X3
Rho guanine nucleotide exchange factor 12, transcript variant X5
rho guanine nucleotide exchange factor 12 isoform X1
rho guanine nucleotide exchange factor 12 isoform X2
rho guanine nucleotide exchange factor 12 isoform X3
rho guanine nucleotide exchange factor 12 isoform X4
rho guanine nucleotide exchange factor 12 isoform X5
Rho guanine nucleotide exchange factor 12, transcript variant X6
Rho guanine nucleotide exchange factor 12, transcript variant X7
rho guanine nucleotide exchange factor 12 isoform X6
glutamate ionotropic receptor kainate type subunit 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 4 isoform X1
glutamate receptor ionotropic, kainate 4 isoform X5
glutamate receptor ionotropic, kainate 4 isoform X2
glutamate receptor ionotropic, kainate 4 isoform X6
glutamate receptor ionotropic, kainate 4 isoform X3
glutamate ionotropic receptor kainate type subunit 4, transcript variant X6
glutamate receptor ionotropic, kainate 4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tubulin-specific chaperone cofactor E-like protein, transcript variant X4
tubulin-specific chaperone cofactor E-like protein, transcript variant X5
tubulin-specific chaperone cofactor E-like protein, transcript variant X1
tubulin-specific chaperone cofactor E-like protein, transcript variant X2
tubulin-specific chaperone cofactor E-like protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
tubulin-specific chaperone cofactor E-like protein, transcript variant X3
tubulin-specific chaperone cofactor E-like protein isoform X1
uncharacterized LOC101953740, transcript variant X13
uncharacterized LOC101953740, transcript variant X4
uncharacterized LOC101953740, transcript variant X12
uncharacterized LOC101953740, transcript variant X5
uncharacterized LOC101953740, transcript variant X11
uncharacterized LOC101953740, transcript variant X3
uncharacterized LOC101953740, transcript variant X15
uncharacterized LOC101953740, transcript variant X10
uncharacterized LOC101953740, transcript variant X7
uncharacterized LOC101953740, transcript variant X1
uncharacterized LOC101953740, transcript variant X8
uncharacterized LOC101953740, transcript variant X6
uncharacterized LOC101953740, transcript variant X14
uncharacterized LOC101953740, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC101953740 isoform X1
uncharacterized LOC101953740, transcript variant X9
uncharacterized protein LOC101953740 isoform X2
sterol-C5-desaturase, transcript variant X3
sterol-C5-desaturase, transcript variant X2
sterol-C5-desaturase, transcript variant X1
sortilin related receptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
sortilin related receptor 1, transcript variant X1
sortilin related receptor 1, transcript variant X2
ubiquitin associated and SH3 domain containing B, transcript variant X1
ubiquitin-associated and SH3 domain-containing protein B isoform X1
ubiquitin associated and SH3 domain containing B, transcript variant X3
ubiquitin associated and SH3 domain containing B, transcript variant X2
ubiquitin-associated and SH3 domain-containing protein B isoform X2
ubiquitin-associated and SH3 domain-containing protein B isoform X3
cytotoxic and regulatory T cell molecule
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytotoxic and regulatory T-cell molecule
junctional cadherin complex regulator, transcript variant X1
junctional cadherin complex regulator, transcript variant X2
junctional cadherin complex regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
heat shock protein family A (Hsp70) member 8
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00016
GRAM domain containing 1B, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X20
GRAM domain containing 1B, transcript variant X23
GRAM domain containing 1B, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X22
GRAM domain containing 1B, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
GRAM domain containing 1B, transcript variant X2
GRAM domain containing 1B, transcript variant X4
GRAM domain containing 1B, transcript variant X3
GRAM domain containing 1B, transcript variant X1
GRAM domain containing 1B, transcript variant X5
GRAM domain containing 1B, transcript variant X6
GRAM domain containing 1B, transcript variant X7
GRAM domain containing 1B, transcript variant X9
GRAM domain containing 1B, transcript variant X11
GRAM domain containing 1B, transcript variant X10
GRAM domain containing 1B, transcript variant X8
GRAM domain containing 1B, transcript variant X13
GRAM domain containing 1B, transcript variant X12
sodium voltage-gated channel beta subunit 3, transcript variant X2
sodium voltage-gated channel beta subunit 3, transcript variant X1
ATPase H+/K+ transporting non-gastric alpha2 subunit
potassium-transporting ATPase alpha chain 2
multiple epidermal growth factor-like domains protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
beta-1,3-glucuronyltransferase 1, transcript variant X2
beta-1,3-glucuronyltransferase 1, transcript variant X3
beta-1,3-glucuronyltransferase 1, transcript variant X4
beta-1,3-glucuronyltransferase 1, transcript variant X1
beta-1,3-glucuronyltransferase 1, transcript variant X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 isoform X2
beta-galactosidase-1-like protein 2, transcript variant X2
beta-galactosidase-1-like protein 2, transcript variant X1
beta-galactosidase-1-like protein 2, transcript variant X3
beta-galactosidase-1-like protein 2 isoform X3
beta-galactosidase-1-like protein 2 isoform X2
beta-galactosidase-1-like protein 2 isoform X1
acyl-CoA dehydrogenase family member 8, transcript variant X1
isobutyryl-CoA dehydrogenase, mitochondrial isoform X1
acyl-CoA dehydrogenase family member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
isobutyryl-CoA dehydrogenase, mitochondrial isoform X2
thymocyte nuclear protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X3
vacuolar protein sorting-associated protein 26B
non-SMC condensin II complex subunit D3, transcript variant X1
non-SMC condensin II complex subunit D3, transcript variant X2
condensin-2 complex subunit D3 isoform X1
condensin-2 complex subunit D3 isoform X2
immunoglobulin superfamily member 9B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
immunoglobulin superfamily member 9B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 55% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: spermatogenesis-associated protein 19, mitochondrial
opioid binding protein/cell adhesion molecule like
opioid-binding protein/cell adhesion molecule
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ADAM metallopeptidase with thrombospondin type 1 motif 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 15
ADAM metallopeptidase with thrombospondin type 1 motif 8
A disintegrin and metalloproteinase with thrombospondin motifs 8
zinc finger and BTB domain containing 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger and BTB domain containing 44, transcript variant X1
zinc finger and BTB domain containing 44, transcript variant X2
zinc finger and BTB domain-containing protein 44 isoform X1
zinc finger and BTB domain-containing protein 44 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ST14 transmembrane serine protease matriptase
LOW QUALITY PROTEIN: suppressor of tumorigenicity 14 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappaB binding protein, transcript variant X4
nuclear factor related to kappaB binding protein, transcript variant X1
nuclear factor related to kappaB binding protein, transcript variant X3
nuclear factor related to kappa-B-binding protein isoform X2
nuclear factor related to kappa-B-binding protein isoform X1
PR domain zinc finger protein 10 isoform X2
PR domain zinc finger protein 10 isoform X1
PR domain zinc finger protein 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PR domain zinc finger protein 10 isoform X3
amyloid beta precursor like protein 2, transcript variant X1
amyloid beta precursor like protein 2, transcript variant X3
amyloid beta precursor like protein 2, transcript variant X2
amyloid beta precursor like protein 2, transcript variant X4
amyloid beta precursor like protein 2, transcript variant X5
amyloid beta precursor like protein 2, transcript variant X7
amyloid beta precursor like protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho GTPase activating protein 32, transcript variant X2
Rho GTPase activating protein 32, transcript variant X1
Rho GTPase activating protein 32, transcript variant X4
Rho GTPase activating protein 32, transcript variant X3
Rho GTPase activating protein 32, transcript variant X5
Rho GTPase activating protein 32, transcript variant X6
rho GTPase-activating protein 32 isoform X1
rho GTPase-activating protein 32 isoform X3
rho GTPase-activating protein 32 isoform X4
rho GTPase-activating protein 32 isoform X2
rho GTPase-activating protein 32 isoform X5
Rho GTPase activating protein 32, transcript variant X8
Rho GTPase activating protein 32, transcript variant X7
rho GTPase-activating protein 32 isoform X6
potassium inwardly rectifying channel subfamily J member 5, transcript variant X1
potassium inwardly rectifying channel subfamily J member 5, transcript variant X2
G protein-activated inward rectifier potassium channel 4 isoform X1
G protein-activated inward rectifier potassium channel 4 isoform X2
potassium inwardly rectifying channel subfamily J member 1, transcript variant X8
potassium inwardly rectifying channel subfamily J member 1, transcript variant X9
potassium inwardly rectifying channel subfamily J member 1, transcript variant X7
potassium inwardly rectifying channel subfamily J member 1, transcript variant X5
potassium inwardly rectifying channel subfamily J member 1, transcript variant X2
potassium inwardly rectifying channel subfamily J member 1, transcript variant X4
potassium inwardly rectifying channel subfamily J member 1, transcript variant X3
potassium inwardly rectifying channel subfamily J member 1, transcript variant X1
potassium inwardly rectifying channel subfamily J member 1, transcript variant X6
ATP-sensitive inward rectifier potassium channel 1 isoform X1
ATP-sensitive inward rectifier potassium channel 1 isoform X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X4
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X5
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X7
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X8
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X9
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X6
Friend leukemia integration 1 transcription factor isoform X2
Friend leukemia integration 1 transcription factor isoform X6
Friend leukemia integration 1 transcription factor isoform X5
Friend leukemia integration 1 transcription factor isoform X3
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X4
Friend leukemia integration 1 transcription factor isoform X7
ETS proto-oncogene 1, transcription factor, transcript variant X1
ETS proto-oncogene 1, transcription factor, transcript variant X3
ETS proto-oncogene 1, transcription factor, transcript variant X6
ETS proto-oncogene 1, transcription factor, transcript variant X4
ETS proto-oncogene 1, transcription factor, transcript variant X2
ETS proto-oncogene 1, transcription factor, transcript variant X5
kirre like nephrin family adhesion molecule 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
kirre like nephrin family adhesion molecule 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
uncharacterized LOC101953717, transcript variant X1
uncharacterized LOC101953717, transcript variant X2
uncharacterized LOC101953717, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X4
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X8
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X11
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X9
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X5
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X10
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X6
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X7
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X3
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X1
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X5
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
toll/interleukin-1 receptor domain-containing adapter protein
cryptochrome-1-like, transcript variant X4
cryptochrome-1-like, transcript variant X3
cryptochrome-1-like, transcript variant X2
cryptochrome-1-like, transcript variant X1
FAD dependent oxidoreductase domain containing 1
FAD-dependent oxidoreductase domain-containing protein 1
signal recognition particle receptor subunit alpha
family with sequence similarity 118 member B
pulmonary surfactant-associated protein C-like, transcript variant X2
pulmonary surfactant-associated protein C-like, transcript variant X1
pulmonary surfactant-associated protein C-like isoform X2
pulmonary surfactant-associated protein C-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
EI24 autophagy associated transmembrane protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
EI24 autophagy associated transmembrane protein, transcript variant X3
EI24 autophagy associated transmembrane protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
etoposide-induced protein 2.4 homolog isoform X2
EI24 autophagy associated transmembrane protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
etoposide-induced protein 2.4 homolog isoform X1
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A isoform X2
checkpoint kinase 1, transcript variant X2
serine/threonine-protein kinase Chk1 isoform X2
checkpoint kinase 1, transcript variant X1
serine/threonine-protein kinase Chk1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X2
cell adhesion associated, oncogene regulated, transcript variant X1
cell adhesion associated, oncogene regulated, transcript variant X3
cell adhesion molecule-related/down-regulated by oncogenes isoform X1
cell adhesion molecule-related/down-regulated by oncogenes isoform X2
cell adhesion molecule-related/down-regulated by oncogenes isoform X3
V-set and immunoglobulin domain containing 10 like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 10-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
HYLS1 centriolar and ciliogenesis associated, transcript variant X3
HYLS1 centriolar and ciliogenesis associated, transcript variant X5
HYLS1 centriolar and ciliogenesis associated, transcript variant X4
HYLS1 centriolar and ciliogenesis associated, transcript variant X6
HYLS1 centriolar and ciliogenesis associated, transcript variant X2
HYLS1 centriolar and ciliogenesis associated, transcript variant X1
mitochondrial RNA pseudouridine synthase RPUSD4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sialate O-acetylesterase
sperm autoantigenic protein 17, transcript variant X2
sperm autoantigenic protein 17, transcript variant X3
sperm autoantigenic protein 17, transcript variant X1
V-set and immunoglobulin domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 2
endothelial cell adhesion molecule, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
endothelial cell adhesion molecule, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
endothelial cell-selective adhesion molecule isoform X2
endothelial cell-selective adhesion molecule isoform X1
Myb/SANT DNA binding domain containing 2, transcript variant X2
Myb/SANT DNA binding domain containing 2, transcript variant X3
Myb/SANT DNA binding domain containing 2, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 2 isoform X3
myb/SANT-like DNA-binding domain-containing protein 2 isoform X2
myb/SANT-like DNA-binding domain-containing protein 2 isoform X1
Myb/SANT DNA binding domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Myb/SANT DNA binding domain containing 2, transcript variant X4
myb/SANT-like DNA-binding domain-containing protein 2 isoform X4
roundabout guidance receptor 4, transcript variant X1
roundabout guidance receptor 4, transcript variant X2
roundabout guidance receptor 4, transcript variant X3
hepatic and glial cell adhesion molecule, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
hepatocyte cell adhesion molecule isoform X1
hepatic and glial cell adhesion molecule, transcript variant X2
hepatocyte cell adhesion molecule isoform X2
coiled-coil domain containing 15, transcript variant X3
coiled-coil domain containing 15, transcript variant X5
coiled-coil domain containing 15, transcript variant X4
coiled-coil domain containing 15, transcript variant X2
coiled-coil domain containing 15, transcript variant X1
coiled-coil domain-containing protein 15 isoform X4
coiled-coil domain-containing protein 15 isoform X1
coiled-coil domain-containing protein 15 isoform X2
coiled-coil domain-containing protein 15 isoform X3
PBX/knotted 1 homeobox 2, transcript variant X6
PBX/knotted 1 homeobox 2, transcript variant X7
PBX/knotted 1 homeobox 2, transcript variant X3
PBX/knotted 1 homeobox 2, transcript variant X9
PBX/knotted 1 homeobox 2, transcript variant X8
PBX/knotted 1 homeobox 2, transcript variant X4
PBX/knotted 1 homeobox 2, transcript variant X5
PBX/knotted 1 homeobox 2, transcript variant X1
PBX/knotted 1 homeobox 2, transcript variant X2